Article
Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma
1 Jan 2020
Abstract excerpt
Abstract Background IDH-mutant lower-grade gliomas (LGGs) evolve under the selective pressure of therapy, but well-characterized patient-derived cells (PDCs) modeling evolutionary stages are lacking. IDH-mutant LGGs may develop therapeutic resistance associated with chemotherapy-driven hypermutation and malignant progression. The aim of this study was to establish and characterize PDCs, single-cell-derived PDCs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
